Biblio Discovery — Demo Discovery Service

9 results for "Susan Short"

Showing 1–9 · 0.45 seconds · RSS

  1. Journal Article

    Senolytics and senostatics as adjuvant tumour therapy

    Susan Short; Edward Fielder; Satomi Miwa et al.

    EBioMedicine, Vol. 41 · 2019 · English · DOAJ Scopus

    Cell senescence is a driver of ageing, frailty, age-associated disease and functional decline. In oncology, tumour cell senescence may contribute to the effect of adjuvant therapies, as it blocks tumour growth. However, this is frequently incomplete, and tumour cells that recover from senescence…

  2. Journal Article

    Optimising tumour coverage and organ at risk sparing for hypofractionated re-irradiation in glioblastoma

    Christopher J.H. Pagett; John Lilley; Rebecca Lindsay et al.

    Physics and Imaging in Radiation Oncology, Vol. 21 · 2022 · English · DOAJ Scopus

    Background and purpose: Re-irradiation may be used for recurrent glioblastoma (GBM) patients. In some cases Planning Target Volume (PTV) under-coverage is necessary to meet organ at risk (OAR) constraints. This study aimed to develop a Volumetric Modulated Arc Therapy planning solution for GBM…

  3. Journal Article

    Evaluating the repeatability and set-up sensitivity of a large field of view distortion phantom and software for magnetic resonance-only radiotherapy

    Jonathan Wyatt; Stephen Hedley; Emily Johnstone et al.

    Physics and Imaging in Radiation Oncology, Vol. 6 · 2018 · English · DOAJ Scopus

    Background and purpose: Magnetic Resonance (MR)-only radiotherapy requires geometrically accurate MR images over the full scanner Field of View (FoV). This study aimed to investigate the repeatability of distortion measurements made using a commercial large FoV phantom and analysis software and the…

  4. Journal Article

    Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma

    Kelly J. McKelvey; Erica B. Wilson; Susan Short et al.

    Frontiers in Oncology, Vol. 11 · 2021 · English · DOAJ Scopus

    Glioblastoma (GBM) is the most aggressive adult glioma with a median survival of 14 months. While standard treatments (safe maximal resection, radiation, and temozolomide chemotherapy) have increased the median survival in favorable O(6)-methylguanine-DNA methyltransferase (MGMT)-methylated GBM…

  5. Journal Article Full text

    Imaging Spectrum of the Developing Glioblastoma: A Cross-Sectional Observation Study

    Stuart Currie; Kavi Fatania; Russell Frood et al.

    Current Oncology, Vol. 30 No. 7 · 2023 · English · DOAJ Scopus

    Glioblastoma (GBM) has the typical radiological appearance (TRA) of a centrally necrotic, peripherally enhancing tumor with surrounding edema. The objective of this study was to determine whether the developing GBM displays a spectrum of imaging changes detectable on routine clinical imaging prior…

  6. Journal Article

    Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion

    Julia V. Cockle; Anke Brüning-Richardson; Karen J. Scott et al.

    Molecular Therapy: Oncolytics, Vol. 5 No. C · 2017 · English · DOAJ

    Pediatric high-grade glioma (pHGG) and diffuse intrinsic pontine glioma (DIPG) are invasive tumors with poor survival. Oncolytic virotherapy, initially devised as a direct cytotoxic treatment, is now also known to act via immune-mediated mechanisms. Here we investigate a previously unreported…

  7. Journal Article Full text

    EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

    Michael Weller; Martin J. van den Bent; Matthias Preusser et al.

    Nature Reviews Clinical Oncology · 2020 · English · OpenAlex Scopus

    In response to major changes in diagnostic algorithms and the publication of mature results from various large clinical trials, the European Association of Neuro-Oncology (EANO) recognized the need to provide updated guidelines for the diagnosis and management of adult patients with diffuse…

  8. Journal Article

    Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) – protocol for a multi-centre open-label randomised trial

    Stuart Currie; Alexandra Smith; David Sebag-Montefiore et al.

    BMJ Open, Vol. 14 No. 3 · 2024 · English · DOAJ Scopus

    Introduction Glioblastoma (GBM) is the most common adult primary malignant brain tumour. The condition is incurable and, despite aggressive treatment at first presentation, almost all tumours recur after a median of 7 months. The aim of treatment at recurrence is to prolong survival and maintain…

  9. Journal Article

    APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health – study protocol paper for a phase III multicentre, open-label randomised controlled trial

    Charlotte Smith; Martin Klein; Stuart Currie et al.

    BMJ Open, Vol. 15 No. 2 · 2025 · English · DOAJ Scopus

    Introduction Oligodendroglioma (ODG) is a rare type of brain tumour, typically diagnosed in younger adults and associated with prolonged survival following treatment. The current standard of care is maximal safe debulking surgery, radiotherapy (RT) and adjuvant procarbazine, lomustine and…